Evaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in Bolivia

Simple item page
dc.contributor.authorJean‐Philippe Chippaux
dc.contributor.authorA. N. Salas-Clavijo
dc.contributor.authorJorge R. Postigo
dc.contributor.authorDominique Schneider
dc.contributor.authorJosé-Antonio Santalla
dc.contributor.authorLaurent Brutus
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:13:35Z
dc.date.available2026-03-22T14:13:35Z
dc.date.issued2012
dc.descriptionCitaciones: 27
dc.description.abstractThe short treatment should be preferred as it allows reducing the dose of benznidazole as well as the cost of treatment.
dc.identifier.doi10.1093/trstmh/trs004
dc.identifier.urihttps://doi.org/10.1093/trstmh/trs004
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45273
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofTransactions of the Royal Society of Tropical Medicine and Hygiene
dc.sourceUniversité Paris Cité
dc.subjectBenznidazole
dc.subjectMedicine
dc.subjectChagas disease
dc.subjectClinical trial
dc.subjectSerology
dc.subjectRandomized controlled trial
dc.subjectInternal medicine
dc.subjectGroup B
dc.subjectPediatrics
dc.subjectSurgery
dc.titleEvaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in Bolivia
dc.typearticle

Files

Collections

Artículo Científico Publicado